New Delhi [India], Mar 20 (ANI): The Drug Controller General of India (DCGI) has given test licence to 18 companies including international and private companies to conduct coronavirus (COVID-19) tests in India.
To name a few, some of these companies include--Cadila Healthcare Ltd, Zydus Healthcare Ltd, Medsource Healthcare Pvt Ltd, Cosara Diagnostics Pvt Ltd etc, an official informed to ANI.
On Wednesday, ANI had reported about Roche Diagnostics and Biomerieux, the two international companies approached DGCI to conduct COVID-19 tests in India.
"Lot of companies have approached us. Only few of them could fulfil the parameters. Since these are the test licence, first we will do assessment. Then only, we will provide to our laboratory technicians in India," said the official requesting anonymity.
There is a panic among the citizens due to the increasing scare of COVID-19 as the virus has infected 195 people and claimed four lives.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app